…to find the best way to inject your product and it was decided to inject directly after the fracture. We found out post hoc that maybe it would have been…
…is leading the development of the first off-the-shelf CAR-T therapy. CAR-T therapy consists in the infusion of T-cells engineered to better identify and kill cancer cells. The most advanced approaches,…
…a gene that encodes for the ambient light-sensitive MCO protein into retinal cells. These therapies are intended to enable retinal cells to detect light so that patients can see again….
…however it comes with several disadvantages: The stamp only allows one type of protein to be transferred at a time and the user cannot control the density of the biomolecule…
…this inefficiency is that drugs are tested in cell cultures that don’t resemble the natural physiological environment of the cell very well. To improve these cell models, Engitix includes the…
…type of cell therapy where the patient’s immune T-cells are genetically modified to hunt down blood cancer cells. The trial enrolled 29 patients to test the effect of Janssen’s therapy,…
…a drug that takes the shape of an aptamer – single-stranded molecules that bind to targets. “In order to make this suitable for clinical development, we transform it, the non-coding…
…if they need to inoculate this at 10,000-liter bioreactor volumes, they can scale that process up in the Xcellerex APS system.” In fact, scalability is a significant benefit of the…
…interfaces is that lots of time, effort and money are needed to get experts and specialist equipment in one place to link up. This is what the researchers, based in…
…protein is a new target in the fight against cancer. Targeting cell division is not new, but using RNA to target proteins that make up the cell’s skeleton (cytoskeleton) –…
…cancer types. By leveraging these antigens, Epitopea aims to develop therapies that enable the immune system to specifically target and destroy cancer cells while minimizing harm to normal tissues. What…
…fast routes to receive and send fresh samples to their network of collaborators. “The first time we thought it was so cool to just walk out of the lab and…